Rodryg Ramlau Selected Research

Rodryg Ramlau Research Topics

Disease

60	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2002
29	Neoplasms (Cancer) 06/2022 - 03/2003
18	Disease Progression 01/2017 - 04/2007
10	Lung Neoplasms (Lung Cancer) 06/2018 - 07/2003
9	Neutropenia 01/2020 - 06/2006
5	Thrombocytopenia (Thrombopenia) 11/2017 - 06/2006
5	Exanthema (Rash) 01/2017 - 04/2007
5	Anemia 12/2014 - 06/2006
5	Fatigue 11/2012 - 07/2008
4	Adenocarcinoma 01/2022 - 01/2014
4	Adenocarcinoma of Lung 01/2021 - 01/2020
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
4	Malignant Mesothelioma 12/2019 - 04/2008
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2017 - 10/2007
3	Infections 06/2022 - 11/2012
3	Dyspnea (Shortness of Breath) 01/2020 - 10/2007
3	Abdominal Pain (Pain, Abdominal) 12/2012 - 05/2010
3	Hypertriglyceridemia 03/2012 - 04/2008
2	Acne Vulgaris 07/2015 - 05/2009
2	Weight Loss (Weight Reduction) 12/2014 - 08/2006
2	Carcinoma (Carcinomatosis) 12/2012 - 10/2007
2	Pain (Aches) 03/2012 - 11/2011
2	Pleural Effusion (Pleural Effusions) 11/2011 - 04/2008
2	Diarrhea 05/2010 - 04/2007
2	Injection Site Reaction 05/2010 - 07/2008
2	Febrile Neutropenia 05/2010 - 09/2006
1	Ovarian Neoplasms (Ovarian Cancer) 06/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	COVID-19 08/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Anaplastic Thyroid Carcinoma 10/2020
1	Cough 01/2020
1	Chest Pain (Chest Pains) 01/2020
1	Breast Neoplasms (Breast Cancer) 09/2019

Drug/Important Bio-Agent (IBA)

23	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 01/2002
13	PlatinumIBA 01/2020 - 08/2003
12	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2009
10	Pemetrexed (MTA)FDA Link 12/2019 - 04/2008
10	Gemcitabine FDA Link 01/2017 - 01/2002
8	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2011
7	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 03/2009
7	Docetaxel (Taxotere)FDA Link 01/2020 - 08/2003
7	Vinorelbine (Navelbine)FDA LinkGeneric 07/2014 - 08/2003
6	Pharmaceutical PreparationsIBA 06/2022 - 02/2012
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 04/2007
5	Paclitaxel (Taxol)FDA LinkGeneric 06/2022 - 03/2009
5	necitumumabIBA 01/2018 - 03/2015
4	Proteins (Proteins, Gene)FDA Link 06/2022 - 10/2012
4	Monoclonal AntibodiesIBA 10/2020 - 03/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2003
4	Biomarkers (Surrogate Marker)IBA 09/2015 - 04/2008
3	rucaparibIBA 11/2021 - 01/2019
3	AntibodiesIBA 01/2021 - 01/2002
3	ARQ 197IBA 01/2019 - 08/2011
3	Topotecan (Hycamtin)FDA LinkGeneric 08/2015 - 06/2006
3	AntigensIBA 01/2014 - 07/2008
3	Bexarotene (LGD1069)FDA Link 03/2012 - 04/2008
3	Cetuximab (Erbitux)FDA Link 01/2012 - 05/2009
2	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2015
2	VaccinesIBA 08/2021 - 01/2014
2	B7-H1 AntigenIBA 06/2021 - 01/2020
2	pembrolizumabIBA 01/2021 - 01/2020
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 08/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2012 - 03/2009
2	LipidsIBA 03/2012 - 02/2012
2	TG4010IBA 11/2011 - 07/2008
2	Bevacizumab (Avastin)FDA Link 12/2010 - 03/2009
2	thiamine triphosphorate (TTP)IBA 04/2008 - 04/2007
1	Nuclear Proteins (Protein, Nuclear)IBA 06/2022
1	Messenger RNA (mRNA)IBA 06/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022
1	Interferon-gamma (Interferon, gamma)IBA 06/2022
1	Long Noncoding RNAIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Oral ContraceptivesIBA 11/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2021
1	COVID-19 VaccinesIBA 08/2021
1	ElementsIBA 08/2021
1	LigandsIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	spartalizumabIBA 10/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	STA 9090IBA 01/2020
1	osimertinibIBA 01/2020
1	CXC ChemokinesIBA 09/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2019
1	Estrogens (Estrogen)FDA Link 09/2019
1	human ERBB2 proteinIBA 09/2019
1	Chemokine CXCL12IBA 09/2019

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 06/2022 - 08/2003
24	Therapeutics 06/2021 - 03/2003
7	Immunotherapy 01/2022 - 01/2014
2	Salvage Therapy 01/2020 - 01/2012
2	Precision Medicine 09/2017 - 09/2015
1	Neoadjuvant Therapy 10/2021
1	Radiotherapy 01/2021
1	Castration 01/2021